Rhythm Pharmaceuticals (RYTM) Net Cash Flow (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Net Cash Flow of $7.5 million for Q1 2026, down 55.97% year-over-year from $17.0 million in Q1 2025, and up 271.49% quarter-over-quarter from $2.0 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Net Cash Flow (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Net Cash Flow for 11 consecutive years, with $7.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 55.97% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at -$44.4 million (down 184.33% YoY), while the FY2025 annual figure was -$34.9 million, down 219.44% from the prior year.
- Net Cash Flow advanced to $7.5 million in Q1 2026 per RYTM's latest filing, from $2.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $108.5 million in Q2 2024 and bottomed at -$113.5 million in Q3 2024.
- Historically, Net Cash Flow has averaged $162764.7 across 5 years, with a median of $6.1 million in 2023.
- Annual changes were most pronounced in 2023 — Net Cash Flow plunged 193.85% — and 2024, when it jumped 1668.92%.
- Rhythm Pharmaceuticals' Net Cash Flow stood at -$57.4 million in 2022, then soared by 92.48% to -$4.3 million in 2023, then soared by 1040.74% to $40.6 million in 2024, then plunged by 95.05% to $2.0 million in 2025, then soared by 271.49% to $7.5 million in 2026.
- Business Quant data shows RYTM's Net Cash Flow at $7.5 million in Q1 2026, $2.0 million in Q4 2025, and -$83.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 7.47 Mn |
| Mar 31, 2026 | 7.47 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | -83.67 Mn |
| Sep 30, 2025 | -83.67 Mn |
| Jun 30, 2025 | 29.83 Mn |
| Jun 30, 2025 | 29.83 Mn |
| Mar 31, 2025 | 16.96 Mn |
| Mar 31, 2025 | 16.96 Mn |
| Dec 31, 2024 | 40.64 Mn |
| Dec 31, 2024 | 40.64 Mn |
| Sep 30, 2024 | -113.54 Mn |
| Sep 30, 2024 | -113.54 Mn |
| Jun 30, 2024 | 108.54 Mn |
| Jun 30, 2024 | 108.54 Mn |
| Mar 31, 2024 | -6.45 Mn |
| Mar 31, 2024 | -6.45 Mn |